Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Loss of Zbtb32 in NOD mice does not significantly alter T cell responses.

Coley WD, Zhao Y, Benck CJ, Liu Y, Hotta-Iwamura C, Rahman MJ, Tarbell KV.

Version 2. F1000Res. 2018 Mar 14 [revised 2018 Jan 1];7:318. doi: 10.12688/f1000research.13864.2. eCollection 2018.

2.

Study of the Equatorial and Low-Latitude Electrodynamic and Ionospheric Disturbances During the 22-23 June 2015 Geomagnetic Storm Using Ground-Based and Spaceborne Techniques.

Astafyeva E, Zakharenkova I, Hozumi K, Alken P, Coïsson P, Hairston MR, Coley WR.

J Geophys Res Space Phys. 2018 Mar;123(3):2424-2440. doi: 10.1002/2017JA024981. Epub 2018 Mar 30.

3.

Low CD25 on autoreactive Tregs impairs tolerance via low dose IL-2 and antigen delivery.

Hotta-Iwamura C, Benck C, Coley WD, Liu Y, Zhao Y, Quiel JA, Tarbell KV.

J Autoimmun. 2018 Jun;90:39-48. doi: 10.1016/j.jaut.2018.01.005. Epub 2018 Feb 10.

4.

Effect of genetic background on the dystrophic phenotype in mdx mice.

Coley WD, Bogdanik L, Vila MC, Yu Q, Van Der Meulen JH, Rayavarapu S, Novak JS, Nearing M, Quinn JL, Saunders A, Dolan C, Andrews W, Lammert C, Austin A, Partridge TA, Cox GA, Lutz C, Nagaraju K.

Hum Mol Genet. 2016 Jan 1;25(1):130-45. doi: 10.1093/hmg/ddv460. Epub 2015 Nov 12.

5.

Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.

Albrecht I, Wick C, Hallgren Å, Tjärnlund A, Nagaraju K, Andrade F, Thompson K, Coley W, Phadke A, Diaz-Gallo LM, Bottai M, Nennesmo I, Chemin K, Herrath J, Johansson K, Wikberg A, Ytterberg AJ, Zubarev RA, Danielsson O, Krystufkova O, Vencovsky J, Landegren N, Wahren-Herlenius M, Padyukov L, Kämpe O, Lundberg IE.

J Clin Invest. 2015 Dec;125(12):4612-24. doi: 10.1172/JCI81031. Epub 2015 Nov 9.

6.

Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target.

Rayavarapu S, Coley W, Van der Meulen JH, Cakir E, Tappeta K, Kinder TB, Dillingham BC, Brown KJ, Hathout Y, Nagaraju K.

Arthritis Rheum. 2013 Dec;65(12):3248-58. doi: 10.1002/art.38180.

7.

Daily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositis.

Coley W, Rayavarapu S, van der Meulen JH, Duba AS, Nagaraju K.

PLoS One. 2013 Jun 13;8(6):e65970. doi: 10.1371/journal.pone.0065970. Print 2013.

8.

Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness.

Rayavarapu S, Coley W, Kinder TB, Nagaraju K.

Skelet Muscle. 2013 Jun 7;3(1):13. doi: 10.1186/2044-5040-3-13.

9.

Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.

Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, Grodish-Dressman H, Jaiswal JK, Hoffman EP, Brown KJ, Hathout Y, Nagaraju K.

Mol Cell Proteomics. 2013 May;12(5):1061-73. doi: 10.1074/mcp.M112.023127. Epub 2013 Jan 7.

10.

Localization and sub-cellular shuttling of HTLV-1 tax with the miRNA machinery.

Van Duyne R, Guendel I, Klase Z, Narayanan A, Coley W, Jaworski E, Roman J, Popratiloff A, Mahieux R, Kehn-Hall K, Kashanchi F.

PLoS One. 2012;7(7):e40662. doi: 10.1371/journal.pone.0040662. Epub 2012 Jul 10.

11.

The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.

Coley W, Rayavarapu S, Pandey GS, Sabina RL, Van der Meulen JH, Ampong B, Wortmann RL, Rawat R, Nagaraju K.

Arthritis Rheum. 2012 Nov;64(11):3750-9. doi: 10.1002/art.34625.

12.

Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies.

Coley W, Rayavarapu S, Nagaraju K.

Arthritis Res Ther. 2012 Apr 27;14(2):209. doi: 10.1186/ar3791. Review.

13.

Endoplasmic reticulum stress in skeletal muscle homeostasis and disease.

Rayavarapu S, Coley W, Nagaraju K.

Curr Rheumatol Rep. 2012 Jun;14(3):238-43. doi: 10.1007/s11926-012-0247-5. Review.

14.

An update on pathogenic mechanisms of inflammatory myopathies.

Rayavarapu S, Coley W, Nagaraju K.

Curr Opin Rheumatol. 2011 Nov;23(6):579-84. doi: 10.1097/BOR.0b013e32834b41d2. Review.

PMID:
21960036
15.

Erratum to: microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection.

Carpio L, Klase Z, Coley W, Guendel I, Choi S, Van Duyne R, Narayanan A, Kehn-Hall K, Meijer L, Kashanchi F.

J RNAi Gene Silencing. 2010 Jul 12;6(1):E386.

16.

Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase.

Chew LJ, Coley W, Cheng Y, Gallo V.

J Neurosci. 2010 Aug 18;30(33):11011-27. doi: 10.1523/JNEUROSCI.2546-10.2010.

17.

microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection.

Carpio L, Klase Z, Coley W, Guendel I, Choi S, Van Duyne R, Narayanan A, Kehn-Hall K, Meijer L, Kashanchi F.

J RNAi Gene Silencing. 2010 May 29;6(1):386-400.

18.

Absence of DICER in monocytes and its regulation by HIV-1.

Coley W, Van Duyne R, Carpio L, Guendel I, Kehn-Hall K, Chevalier S, Narayanan A, Luu T, Lee N, Klase Z, Kashanchi F.

J Biol Chem. 2010 Oct 15;285(42):31930-43. doi: 10.1074/jbc.M110.101709. Epub 2010 Jun 28.

19.

Novel HIV-1 therapeutics through targeting altered host cell pathways.

Coley W, Kehn-Hall K, Van Duyne R, Kashanchi F.

Expert Opin Biol Ther. 2009 Nov;9(11):1369-82. doi: 10.1517/14712590903257781. Review.

20.

Chromatin dynamics associated with HIV-1 Tat-activated transcription.

Easley R, Van Duyne R, Coley W, Guendel I, Dadgar S, Kehn-Hall K, Kashanchi F.

Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):275-85. doi: 10.1016/j.bbagrm.2009.08.008. Epub 2009 Aug 27. Review.

21.

9-Aminoacridine inhibition of HIV-1 Tat dependent transcription.

Guendel I, Carpio L, Easley R, Van Duyne R, Coley W, Agbottah E, Dowd C, Kashanchi F, Kehn-Hall K.

Virol J. 2009 Jul 24;6:114. doi: 10.1186/1743-422X-6-114.

22.

The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893.

Coley WB.

Clin Orthop Relat Res. 1991 Jan;(262):3-11. No abstract available.

PMID:
1984929
23.

The Diagnosis and Treatment of Bone Sarcoma.

Coley WB.

Glasgow Med J. 1936 Sep;126(3):128-164. No abstract available.

24.

The Diagnosis and Treatment of Bone Sarcoma.

Coley WB.

Glasgow Med J. 1936 Aug;126(2):49-86. No abstract available.

25.

Injury as a Causative Factor in the Development of Malignant Tumors.

Coley WB, Higinbotham NL.

Ann Surg. 1933 Dec;98(6):991-1012. No abstract available.

26.

The Treatment of Sarcoma of the Long Bones.

Coley WB.

Ann Surg. 1933 Mar;97(3):434-60. No abstract available.

27.

MULTIPLE MYELOMA.

Coley WB.

Ann Surg. 1931 Jan;93(1):77-89. No abstract available.

28.

ACCIDENTAL OR COMPENSABLE HERNIA: REPORT OF THE COMMITTEE OF THE AMERICAN RAILWAY ASSOCIATION.

Hopkins CW, Leigh S, Walker JB, Wainwright JM, Coley WB.

Ann Surg. 1929 Dec;90(6):1060-8. No abstract available.

29.

RETROCAECAL INTERNAL HERNIA.

Coley WB, Hoguet JP.

Ann Surg. 1929 Oct;90(4):765-8. No abstract available.

31.
32.
33.
34.

END-RESULTS IN MALIGNANT DISEASE OF THE TESTIS.

Coley WB.

Ann Surg. 1923 Sep;78(3):370-86. No abstract available.

35.

TRAUMATIC AND INDUSTRIAL HERNIA: REPORT OF THE SPECIAL COMMITTEE OF THE MEDICAL SECTION OF THE AMERICAN RAILWAY ASSOCIATION.

Coley WB, Leigh S, Walker JB, Hopkins CW, Hutchison JA.

Ann Surg. 1922 Apr;75(4):467-77. No abstract available.

36.

ACUTE INTESTINAL OBSTRUCTION DUE TO STRANGULATION OF A LOOP OF SMALL INTESTINE BY MECKEL'S DIVERTICULUM.

Coley WB, Fortuine ST.

Ann Surg. 1921 May;73(5):568-77. No abstract available.

37.

SARCOMA OF THE CLAVICLE-END-RESULTS FOLLOWING TOTAL EXCISION.

Coley WB.

Ann Surg. 1920 Aug;72(2):231-56. No abstract available.

38.

FURTHER OBSERVATIONS ON THE CONSERVATIVE TREATMENT OF SARCOMA OF THE LONG BONES.

Coley WB.

Ann Surg. 1919 Dec;70(6):633-60. No abstract available.

40.

MELANOTIC CANCER: WITH A REPORT OF 91 CASES.

Coley WB, Hoguet JP.

Ann Surg. 1916 Aug;64(2):206-41. No abstract available.

41.

PRIMARY NEOPLASMS OF THE LYMPHATIC GLANDS INCLUDING HODGKIN'S DISEASE.

Coley WB.

Ann Surg. 1916 Jan;63(1):35-70. No abstract available.

43.

SOME PROBLEMS IN THE EARLY DIAGNOSIS AND TREATMENT OF SARCOMA OF THE LONG BONES.

Coley WB.

Ann Surg. 1914 Nov;60(5):537-66. No abstract available.

45.
47.

II. Injury as a Causative Factor in Cancer (Continued).

Coley WB.

Ann Surg. 1911 May;53(5):615-50. No abstract available.

48.

I. Injury as a Causative Factor in Cancer.

Coley WB.

Ann Surg. 1911 Apr;53(4):449-88. No abstract available.

49.

V. Sarcoma of the Clavicle: End-Results following Total Excision.

Coley WB.

Ann Surg. 1910 Dec;52(6):776-96. No abstract available.

Supplemental Content

Support Center